|
1) The Diabetes Control and Complications Trial Research Group. The effect of intensive therapy of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-86
|
|
|
|
2) Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995; 28: 103-17
|
|
|
|
|
|
3) UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of conplications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-53
|
|
|
|
|
|
4) Fioretto P, Steffes MW, Sutherland DER, et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998; 339: 69-75
|
|
|
|
|
|
5) 赤井裕輝, 佐藤 博. 糖尿病性腎症は寛解するか. 腎臓. 2001: 24: 70-7
|
|
|
|
|
6) 赤井裕輝. 寛解 (remission) をめざした顕性腎症の治療戦略. 月刊糖尿病. 2009; 1: 79-89
|
|
|
|
|
|
7) Araki S, Haneda M, Sugimoto T, et al. Factors associated with frequent remission of microalbumiuria in patients with type 2 diabetes. Diabetes. 2005; 54: 2983-7
|
|
|
|
|
|
8) Abouna GM, Al-Adnani MS, Kremer GD, et al. Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients. Lancet. 1983; 1274-76
|
|
|
|
|
|
9) Taguma Y, Kitamoto Y, Futaki G, et al. Effect of captooril on heavy proteinuria in azotemic diabetes. N Engl J Med. 1985; 313; 1617-20
|
|
|
|
|
|
10) UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J. 1998; 317: 703-13
|
|
|
|
|
|
11) Estacio RO, Gifford N, Jeffers BW, et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 2000; 23 (Suppl. 2): B54-B64
|
|
|
|
|
|
12) Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE Study and MICRO- HOPE Study. Lancet. 2000, 355: 253-9
|
|
|
|
|
|
13) Hovind P, Rossing P, Tarnow L, et al. Remission and regression in the nephropthy type 1 diabetes when blood pressure is controlled aggressively. Kidney Int. 2001; 60: 277-83
|
|
|
|
|
|
14) Makino H, Haneda M, Babazono T, et al. INNOVATION Study Group. Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes. Diabetes Care. 2007; 30; 1577-8
|
|
|
|
|
|
15) The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of microalbuminuria in patients with type 2 diabetes; The Shiga Microalbuminuria Reduction Trial (SMART). Diabetes Care. 2007; 30: 1581-3
|
|
|
|
|
|
16) Klahr S, Levey AS, Beck GJ, et al. The effect of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med. 1994; 330: 877-84
|
|
|
|
|
|
17) Pedrini MT, Levey AS, et al. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases; a meta-analysis. Ann Intern Med. 1996; 124: 627-32
|
|
|
|
|
|
18) Kasiske BL, Lakatua JD, Ma JZ, et al. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis. 1998; 31: 954-61
|
|
|
|
|
|
19) Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348: 383-93
|
|
|
|
|
|
20) Haraguchi K, Hara S, Ubara Y, et al. Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function. Diabetes Res Clin Pract. 2009; 83: 295-9
|
|
|
|
|
|
21) 赤井裕輝, 早坂恭子, 平井 敏, 他. 緩やかでよいが低蛋白食はやはり必要である. 糖尿病合併症. 2005, 19: 151-5
|
|
|
|
|
|
22) Shikata K, Haneda M, Koya D, et al. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design. Diabetes Res Clin Pract. 2010; 87: 228-32
|
|
|
|
|